Summary by Moomoo AI
Ming Kand Pharmaceuticals announces that a Board Meeting will be held on Monday, 29 April 2024 to consider and approve the Group's first quarter results for the three months ended 31 March 2024 and their release. The members of the Board of Directors include the Executive Directors Dr. Li Keung, Dr. Chen Minchang, Mr. Hu Cheng Guo, Dr. Yang Ching and Mr. Zhang Chahui; the Non-Executive Directors Mr. Tou Xiao Hui and Dr. Wu Yibing; and the Independent Non-Executive Directors Ms. Lu Shao-hua, Dr. Yu Wei, Dr. Zhang Xin, Ms. Zhan Chi-ling and Mr. Fung Dai. The meeting will provide investors with an up-to-date overview of the company's financial performance.